# Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia

> **NCT03225248** · PHASE3 · COMPLETED · sponsor: **Korea United Pharm. Inc.** · enrollment: 143 (actual)

## Conditions studied

- Functional Dyspepsia

## Interventions

- **DRUG:** UI05MSP015CT
- **DRUG:** Gasmotin

## Key facts

- **NCT ID:** NCT03225248
- **Lead sponsor:** Korea United Pharm. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11-05
- **Primary completion:** 2015-09-05
- **Final completion:** 2015-10-12
- **Target enrollment:** 143 (ACTUAL)
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03225248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03225248, "Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03225248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*